Differential expression of membrane metallo-endopeptidase, MME, in cancers of the breast.

Shahan Mamoor

DOI: https://doi.org/10.31219/osf.io/sypdt

2021-04-19

Abstract:Breast cancer affects women at relatively high frequency (1). We mined published microarray datasets (2, 3) to determine in an unbiased fashion and at the systems level genes most differentially expressed in the primary tumors of patients with breast cancer. We report here significant differential expression of the gene encoding membrane metallo-endopeptidase, MME, when comparing primary tumors of the breast to the tissue of origin, the normal breast. MME was also differentially expressed in the tumor cells of patients with triple negative breast cancer. MME mRNA was present at significantly lower quantities in tumors of the breast as compared to normal breast tissue. Analysis of human survival data revealed that expression of MME in primary tumors of the breast was correlated with distant metastasis-free survival in patients with HER2+ cancer, demonstrating a relationship between primary tumor expression of a differentially expressed gene and patient survival outcomes influenced by molecular subtype. MME may be of relevance to initiation, maintenance or progression of cancers of the female breast.